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Abstract: We have previously reported on hypoxia/reoxygenation-induced premature senescence in neonatal
rat cardiomyocytes. In this research, we investigated the effects of p21WAF1 (p21) in hypoxia/reoxygenation-in-
duced senescence, using H9c2 cells. A plasmid overexpressing wild type p21WAF1 and a plasmid expressing small
hairpin RNA (shRNA) targeting p21WAF1 were constructed, and transfected into H9c2 cells to control the p21
expression. Hypoxia/reoxygenation conditions were 1% O2 and 5% CO2, balancing the incubator chamber with
N2 for 6 h (hypoxia 6 h), then 21% oxygen for 8 h (reoxygenation 8 h). Cell cycle was examined using flow
cytometry. Senescence was assessed using b-galactosidase staining. The expression of p53, p21, p16INK4a, and
cyclin D1 was assayed using Western blotting. At hypoxia 6 h, cells overexpressing p21 had a larger G1 distribu-
tion, stronger b-galactosidase activity, and lower cyclin D1 expression compared to control cells, while the oppo-
site results and higher p53 expression were obtained in p21-knockdown cells. At reoxygenation 8 h, p21-silenced
cells had a smaller percentage of G1 cells, weaker b-galactosidase activity and lower 16INK4a expression, and
higher cyclin D1 expression, but the overexpression group showed no difference. Taken together, this data im-
plies that p21WAF1 is important for the hypoxia phase, but not the reoxygenation phase, in the H9c2 senescence
process. (Folia Histochemica et Cytobiologica 2011, Vol. 49, No. 3, 445–451)
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Introduction
Cellular senescence is defined as cell cycle arrest
caused by DNA damage or other stress [1]. Various
types of stimuli such as telomere shortening, onco-
genic or tumor suppressor signals, and DNA damage
can trigger cellular senescence [2]. Cellular senescence
is characterized by an increase in senescence-associ-
ated b-galactosidase activity, cell cycle arrest and ex-
pression of gene-associated senescence [2]. Cellular
senescence has been observed in many cell types [3],
including cardiomyocytes [4]. Cardiomyocytes were
thought to be a terminally differentiated cell type un-
able to undergo mitosis; however, recent evidence of
cardiac regeneration has been reported. Anversa et
al. [5] demonstrated cardiomyocyte cell division in
adult human hearts, and proliferation and cell divi-
sion in a fraction of cardiomyocytes were discovered
in young, as well as in adult and elderly, hearts. Car-
diac stem cell senescence has also been reported [6].
Oxidative stress is the most important factor in
the aging process of cardiomyocytes [7].
Zhang et al. [8] reported hypoxia-reoxygenation
induced premature senescence in Fanconi anemia
bone marrow hematopoietic cells. Our previous study
[9] also found that exposure to hypoxia/reoxygenation
induced premature senescence in neonatal Sprague-
-Dawley rat cardiomyocytes. Currently, aging per se is
considered a risk factor for reduced cardiac function
and heart diseases [7], and senescent cardiomyocytes
have been found in patients with heart failure, sug-
gesting that cellular senescence plays a role in the
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course of heart failure [4]. Jugdutt et al. reported [10]
that aging is related to reperfusion injury and left ven-
tricular remodeling after reperfused ST-segment-el-
evation myocardial infarction. Therefore, investigat-
ing the molecular mechanism of cardiomyocyte ag-
ing is important for both clinical and basic cardiology
research.
A universal inhibitor of cyclin-dependent kinases
(CDK), p21WAF1 also negatively regulates the cell cy-
cle by binding and inactivating most cyclin-CDK com-
plexes. Being closely related to p16INK4a (p16) and p53,
p21WAF1 plays an essential role for cells, not only with
regards to physiological conditions, but also in re-
sponse to DNA damage by regulating cell cycle pro-
gression, apoptosis, and transcription [11]. Senescent
cardiomyocytes enter a stage characterized by irre-
versible cell-cycle arrest, upregulation of p16INK4a and
p53, and reduction in telomere length after exposure
to stress [7]. However, the function of p21WAF1 in car-
diomyocyte aging induced by hypoxia/reoxygenation
is not clear. Therefore, in the current study, we inves-
tigated the role of p21WAF1 in hypoxia/reoxygenation-
induced aging of cardiomyocytes.
Material and methods
Experimental animals and cell culture. All animal exper-
iments were performed using protocols approved by our
Institutional Animal Care and Use Committee and con-
formed to the Guide for the Care and Use of Laboratory
Animals of Nanjing Medical University, China. Rat cardi-
omyocyte H9c2 cells were from American Type Culture
Collection, and cultured in Dulbecco’s Modified Eagle
Medium (DMEM) containing 10% fetal bovine serum, pen-
icillin (100 units/ml) and streptomycin (100 μg/ml).
Preparation of RNA and RT-PCR. Total RNA was isolat-
ed from cultured cells with TRIZOL (Invitrogen, USA)
according to the manufacturer’s protocol. RNA was con-
centrated by Biophotometer (Eppendorf, Germany), and
cDNA synthesized using M-MuLV reverse transcriptase
(RT) and random primers according to the manufacturer’s
recommendations (Fermentas, USA). Semiquantitative
PCR analysis used PCR Master Mix (Fermentas, USA).
Western blotting. Cultured cells in three groups were
washed with iced PBS and lysed with 2 × SDS lysis buffer.
Protein concentration was determined by the Lowry meth-
od and 50 μg of whole cell lysate was loaded and electro-
phoresed on 10% SDS-polyacrylamide gels, and transferred
to nitrocellulose membranes (Bio-Rad, USA). Membranes
were blocked with 5% skim  milk in TBST and incubated
with anti-p16INK4a (1:1,000, Abcam, UK), or anti-p21WAF1
monoclonal antibodies (1:300 Lifespan Biosciences, USA),
or anti-p53 (1:800, Abcam, UK), or anti-cyclin D1 (1:1,000,
GenWay Biotech, USA) polyclonal antibodies for 16 h at
4°C. A GAPDH antibody (Sigma, USA) was used as a pro-
tein loading control. After 1-h incubation at room temper-
ature with secondary antibody linked to horseradish perox-
idase, the membranes were washed and the membrane blots
were developed with EZ/ECL reagents (Pierce). The quan-
tity of protein was determined using ‘Quantity One’ (Bio-
Rad, USA).
Construction of plasmids PRNAT-p21WAF1-cGFP and
PRNAT-silencer. ICR mice (4–6 weeks old, 23.5 ± 2.4 g)
were given 50% alcohol at 12 ml/kg body weight, and sacri-
ficed 12 h later without feeding. Total RNA was extracted
from liver tissues, and cDNAs encoding full-length mouse
p21WAF1 obtained by RT-PCR using primers: F: 5'-GG GGAT-
TC ATGTCCAATCCTGGTGATGTCCGAC -3'
R: 5'-GG GGTACC TCAGGGTTTTCTCTTGCAGAA-
GACC -3'
After sequencing, full-length p21WAF1 cDNA was sub-
cloned into plasmid PRNAT-U6.1/neo-cGFP (GenScript Cor-
poration, USA) to generate PRNAT- p21WAF1-cGFP. Small
hairpin RNA (shRNA) against p21WAF1 was designed and syn-
thesized by GenScript Corporation (USA) with the sequence:
5'-CGTGTCGCTGTCTTGCACTCTGGTTCAAGAGAC-
CAGAGTGCAAGACAGCGACATTTTTTCCAA -3'.
Cloning into plasmid PRNAT-U6.1/neo-cGFP, generated
plasmid PRNAT-silencer. Plasmid PRNAT-U6.1/Neo/CTL
was used as a control and contained the noncoding sequence:
5 ' - C GT C G C T TA C C G AT T C A G A AT G GT T G -
ATATCCGCCATTCTGAATCGGTAAGCGATTTTTT-
CCAACG-3'.
H9c2 transfection and verification. The three plasmids
(PRNAT-p21WAF1-cGFP, PRNAT-silencer, and PRNAT-
-U6.1/Neo/CTL) were transfected into H9c2 cells with Li-
pofectamine 2000 (Invitrogen, USA) according to the man-
ufacturer’s instructions, to generate p21-overexpressing,
p21-silenced, and control group cells. Cells were cultured
with G418 (400 μg/ml) for two weeks after transfection,
and positive clones were picked. p21WAF1 expression was
observed by RT-PCR and Western blotting methods as
described above.
Hypoxia/reoxygenation. As illustrated in our previous study
[9], suspended cells were diluted to 1.0 × 105 cells/ml, and
10 ml seeded into 75 cm2 plastic culture flasks and cultured
for 48 h. The treatment conditions for the three group cells
were as follows: normoxia, cells were continuously incubat-
ed in 5% CO2 and 95% air at 37°C; hypoxia/reoxygenation,
cells were cultured with D-Hanks solution, and placed in
a modular incubator chamber (BioSpherix, USA) with 1%
O2, 5% CO2, balanced with N2 for 6 h (hypoxia 6 h), then
exposed to 21% oxygen for 8 h (reoxygenation 8 h).
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Cells cycle analysis. Cells were harvested, fixed in 70%
ethanol, and stored at –20°C before washing twice with
ice-cold phosphate-buffered saline (PBS) and incubating
with RNase and propidium iodide, a DNA-intercalating
dye. Cell cycle phase analysis was performed using a Bec-
ton Dickinson Facstar flow cytometer equipped with Mod-
fit 3.0 software.
b-galactosidase staining. A b-galactosidase colorimetric
assay kit (Cell Signaling Technology, USA) was used accord-
ing to the manufacturer’s protocol. The percentage of se-
nescence-associated-b-galactosidase positive cells was de-
termined by counting blue cells under bright-field illumina-
tion, using the total number of control cells in the same phase
as a standard. The percentage of positive cells represented
the intensity of the b-galactosidase activity.
Statistical analysis. All experiments were performed in trip-
licate and results analyzed by SPSS 13.0 software (SPSS Inc,
USA). Data was expressed as mean ± standard deviation
(SD). One-way analysis of variance (ANOVA) was used and
an least significant difference (LSD) test performed for
group comparisons. A p value of less than 0.05 was consid-
ered significant.
Results
Expression of p21WAF1 increased at the mRNA and
protein levels in cells in the p21-overexpressing group,
and decreased in the p21-silenced group (Figure 1).
At hypoxia 6 h and reoxygenation 8 h, p21WAF1 expres-
sion showed a lower level in the p21-silenced group
and a higher level in the p21-overexpressing group
(Figures 2A, 2B). Both plasmids affected p21WAF1 ex-
pression in H9c2 cells.
Compared to cells in normoxia condition, senes-
cence markers changed substantially in cells exposed
to hypoxia/reoxygenation. At both hypoxia and reox-
ygenation phases, all three groups of cells had larger
distribution of G1 cells (Figure 3), stronger b-galac-
tosidase activity (Figure 4), higher p16INK4a and p53
Figure 1. The p21WAF1 expression of H9c2 cells at the
mRNA level (A) and the protein level (B). Total mRNA
and proteins of the p21-silenced group (S), control group
(C) and p21-overexpressing (O) group were extracted and
tested by RT-PCR (A) and Western blotting methods (B);
*means significantly different at p < 0.05
Figure 2. The p21-silenced group (S), control group (C),
and p21-overexpressing group (O) were treated with
hypoxia/reoxygenation. Total proteins were extracted and
assayed by Western blotting (A) method at normoxia (N),
hypoxia 6 h (H6), and reoxygenation 8 h (R8) as described
in ‘Material and methods’. The expressions of protein
p21WAF1(B), p16INK4a (C), p53 (D), and cyclin D1 (E) were
analyzed respectively, and relative value was determined by
normalization with GAPDH; * means significantly diffe-
rent at p < 0.05 compared to the same group itself in
normoxia condition; # means significantly different at
p < 0.05 compared to the control group in the same
treatment condition
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expression, and lower cyclinD1 (Figures 2A, 2C–E)
expression compared to those in normal conditions.
The results show that senescence was induced in all
groups by hypoxia/reoxygenation.
At hypoxia 6 h, senescence markers in the p21-
-overexpressing group, G1 cell percentage, and per-
centage of b-galactosidase staining and p16INK4a ex-
pression were much higher than in the control group
(Figures 2C, 3, 4), whereas cyclin D1 expression was
much lower (Figure 2E). The opposite results were
observed in the p21-silenced group (Figures 2C, 2E,
3, 4). This data shows that p21WAF1 expression was in-
volved in the hypoxia phase of the hypoxia/reoxygen-
ation-induced senescence of H9c2 cells.
At reoxygenation 8 h, although p21WAF1 expression
was depressed in the p21-silenced group, the senes-
cence was still induced, and senescence markers were
still higher than in the normoxia condition, and still
lower than in both the control group and the p21-
-overexpressing group (Figures 3, 4). However, when
p21WAF1 was overexpressed, no significant differences
were seen in G1 cell percentage, b-galactosidase stain-
ing, and p16INK4a, cyclinD1, or p53 expression between
the p21-overexpressing group and the control group
(Figures 2C–E, 3, 4), indicating that the effect of
p21WAF1 was attenuated in the reoxygenation phase.
Thus, p21WAF1 affected the senescence process mainly in
the hypoxia phase and not in the reoxygenation phase.
Discussion
Expression of p21WAF1 is elevated in many aging cells
[12–13], and this protein protects adult stem cells from
acute genotoxic stress, and impairs stem cell function
in stem cell aging [14]. Accumulation of p21WAF1 leads
to growth arrest, and its suppression causes a delay in
senescence [15]. The plasmids PRNAT- p21WAF1-cGFP
and PRNAT-silencer were constructed to control
p21WAF1 expression. Using those plasmids, and via hy-
poxia/reoxygenation treatment of H9c2 cells, p21WAF1
expression was found to be increased in all three group
cells after hypoxia/reoxygenation, indicating that
p21WAF1 was induced for its DNA repair function when
the damage had occurred because of the oxidative
stress. However, because of the plasmids PRNAT-
-p21WAF1-cGFP and PRNAT-silencer, p21WAF1 was ef-
fectively controlled in p21-overexpressing group and
p21-silenced group at different treatment conditions.
Activity of b-galactosidase, as well as expression of
p16INK4a and p53, increased with hypoxia/reoxygenation,
and was accompanied by cell cycle arrest, suggesting that
cellular senescence occurred in all three cell groups.
Figure 3. After being treated with hypoxia/reoxygenation, cells of the p21-silenced group (S), control group (C)
and p21-overexpressing group (O) were collected, and at least 1 × 104 cells were tested by flow cytometry (A). The G1
phase percentage of the three groups at normoxia (N), hypoxia 6 h (H6) and reoxygenation 8 h (R8) were described (B);
*means significantly different at p < 0.05 compared to the same group itself in normoxia condition;
# means significantly different at p < 0.05 compared to the control group in the same treatment condition
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Figure 4. (A) b-galactosidase staining in the three groups and positive cells (senescent cells) showed blue in the pictures
(× 200). The percentage of positive cells represented the b-galactosidase activity of the three groups, and was analyzed
(B); * means significantly different at p < 0.05 compared to the same group itself in normoxia condition;
# means significantly different at p < 0.05 compared to the control group in the same treatment condition
Studies have shown that b-galactosidase activity is
a marker of premature senescence in many types of
cells [2], and adult mouse cardiomyocytes [16]. The
activity of b-galactosidase increases with expression
of the senescence-associated protein p21 [9]. The find-
ings of the present study conform to these previously
reported results. At the hypoxia phase, the number
of b-galactosidase-positive cells differed according to
p21 expression, indicating that p21 affected senes-
cence in the hypoxia phase of hypoxia/reoxygenation-
treated cardiomyocytes; however, the effect was weak-
ened at reoxygenation phase.
Cell cycle arrest is an important characteristic of cel-
lular senescence. First, p21WAF1 induces G1 arrest by di-
rectly inhibiting cyclin D1 [17]. Yoshiba et al. [18] re-
ported that hypoxia induces G1 phase cell cycle arrest
in oral cancer cells. In addition, p21 mediates cell cycle
arrest in response to DNA damage, not only by inacti-
vating G1-phase cyclins/CDKs complexes, but also
through direct interaction with PCNA to inhibit DNA
replication [11]. Consistent with these results, the find-
ings of the current study suggest that p21 expression
might control the cell cycle by inhibiting cyclin D1. Sim-
ilar results were obtained by Waldman et al. [19], who
also found that p21WAF1 is necessary for p53-mediated
G1 arrest in human cancer cells. However, the results
of the current study show that, at reoxygenation phase,
p21’s effect on the cell cycle was attenuated, and other
factors had minor or partial effects.
When cellular senescence occurred, the expression
of senescence-related proteins such as p53, p21, and
p16 INK4a changed. As described in a previous report [20],
during chronic hypoxia, cells would lower their normoxic
set-point such that the return to normoxic pO2 after
chronic hypoxia results in perceived hyperoxia. DNA
was damaged by the oxygen toxicity after hypoxia/reox-
ygenation and induction of p53, which is necessary for
the signaling to p53-dependent senescence [2]. The p21
protein, a target of p53, is closely involved in cellular
senescence, and can be activated by p53-dependent [21]
and p53-independent [22] pathways. As can be seen in
the current study, p21 expression was not completely
parallel with p53. That meant that p21 was induced both
by p53 indirectly and by DNA damage directly. Cells
reportedly enter into senescence, in which repair to
phase damages take place; p21WAF1 may be directly in-
volved in DNA repair [11]. At the hypoxia phase, DNA
repair could be partly delayed in the p21 silenced cell
group, and as a reaction to feedback, p53 expression
was higher than the other two groups accordingly.
The different senescent extent of the three groups
suggested another factor could contribute to the se-
nescence process both independently and by co-op-
eration with p21WAF1.
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We think p16INK4a could be the one. Close inter-
action between p21WAF1 and p16INK4a has been sug-
gested in articles. Huang et al. [23] reported down-
-regulation of p21WAF1 that caused cells to express
less p16 INK4a mRNA and p16 INK4a, possibly program-
ming the cell senescence process by triggering se-
nescence when p16 INK4a protein accumulates. Re-
cently, an intrinsic cooperation between p16INK4a
and p21WAF1 in the onset of cellular senescence was
established [24, 25]. In the present study, p16INK4a
increased in all three groups, and the results imply
that p16INK4a was induced in H9c2 cells after hy-
poxia/reoxygenation, and was further affected by
p21WAF1 levels. At the reoxygenation phase, senes-
cence markers still increased, such as G1 phase
percentage and b-galactosidase activity, which
meant that senescence might still proceed when p16
INK4a was expressed, despite p21WAF1 repression.
Some reports indicated that [26] senescence de-
layed when p16 INK4a was repressed, and p16INK4a
could initiate the cellular senescence [27] and also
induced the G1 phase arrest accompanied by in-
crement of b-galactosidase activity [28].
Hence, the results suggest that the effects of
p21WAF1 in this process were attenuated for the in-
crease of p16INK4a induced by both oxidative stress and
p21WAF1 at reoxygenation. But when p21was knocked
down, p16INK4a expression was lower, and the senes-
cent markers were also weaker. That meant that p21
played a role, partly at least, in the reoxygenation
phase. Otherwise, some reports suggested p21WAF1
mainly adjusted the early stage of cellular senescence
[29], and p16 INK4a mainly adjusted the late stage of
cellular senescence [30]; and another [31] suggested
that at late-passage of senescence, cells consistently
exhibited increased expression of p16INK4a seen at both
the mRNA and protein level, but the expression of
p21WAF1 mRNA did not differ significantly between
early- and late-passage.
In short, p21WAF1 is important for the hypoxia phase
of senescence; however, during reoxygenation, the
increase in p16INK4a induced by cellular damage con-
trols the cellular senescence processes associated with
p21WAF1.
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